A Study to Investigate the Effects of Imatinib on Pulmonary Vascular Dysfunction in a Human Model of Lung Injury

NCT03328117 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lung Injury

Interventions

DRUG: Imatinib
DRUG: Placebo oral capsule

Sponsor

Exvastat Ltd.

Collaborators

[object Object]